Bio-Europe Week underway: Pila Pharma stands out from the GLP-1 crowd and provides an update

2026-11-09 16:29:00

BIO-Europe is under way in Cologne, and obesity remains one of the most talked-about areas on the partnering floor. While much of the attention is still on GLP-1 drugs, Pila Pharma is pitching a different approach: a TRPV1-targeting pill for obesity, with the first participants in its new study dosed in October. BioStock caught up with CEO Gustav Gram on the first day of the conference to hear about the mood on the floor and what the company hopes to take home.

Watch the interview at biostock.se :

https://biostock.se/en/2026/11/bio-europe-week-underway-pila-pharma-stands-out-from-the-glp-1-crowd-and-provides-an-update/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Follow BioStock
Read the latest news, keep track of upcoming events, explore BioStock Analytics' in-depth analyses and watch the latest videos! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook! 

About BioStock
BioStock is the Nordic region's leading information channel for life science. Focusing on biotech, medtech, diagnostics and pharmaceutical development, we provide daily news updates, in-depth analyses via BioStock Analytics, exclusive interviews and innovation-driving networking events – all to keep you up to date on developments in the sector.
BioStock – Connecting Innovation & Capital.